Clinical Trials Directory

Trials / Completed

CompletedNCT03515421

Project Frazier 3 Regulatory Clinical Evaluation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
379 (actual)
Sponsor
LifeScan Scotland Ltd · Industry
Sex
All
Age
12 Years
Healthy volunteers
Accepted

Summary

Clinical Evaluation of Blood Glucose Monitoring Systems (BGMSs)

Detailed description

User performance, system use, system accuracy, user instruction for use and marketing claims evaluation of Blood Glucose Monitoring Systems.

Conditions

Interventions

TypeNameDescription
DEVICEFrazier 3 VerioIn vitro diagnostic device (IVDD)
DEVICEFrazier 3 UltraPlusIn vitro diagnostic device (IVDD)

Timeline

Start date
2018-04-09
Primary completion
2018-06-18
Completion
2018-06-18
First posted
2018-05-03
Last updated
2020-09-10

Locations

4 sites across 2 countries: Germany, United Kingdom

Source: ClinicalTrials.gov record NCT03515421. Inclusion in this directory is not an endorsement.